V938
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for V938, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001) [Phase 1]